King's College London and AviadoBio, a spinoff from our School of Neuroscience, have announced an expanded license agreement, granting AviadoBio exclusive rights to apply their gene silencing platform to all human therapeutics areas.
www.kcl.ac.uk/news/kings-c...
King's College London and AviadoBio have announced an expanded license agreement providing AviadoBio exclusive rights to apply the vMiX™ RNAi gene silencing platform across all human therapeutic areas...
